SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001933414-24-000018
Filing Date
2024-05-23
Accepted
2024-05-23 16:20:51
Documents
1
Period of Report
2024-05-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1716495632.html 4  
1 FORM 4 wk-form4_1716495632.xml 4 3952
  Complete submission text file 0001933414-24-000018.txt   5462
Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Issuer) CIK: 0001933414 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MINERALYS THERAPEUTICS, INC. 150 N. RADNOR CHESTER RD, STE. F200 RADNOR PA 19087
Business Address
Litzka Olivier (Reporting) CIK: 0001963940 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41614 | Film No.: 24978569